文献速递乳腺MR

乳腺癌新辅助化疗前MR影像计算机纹理分析特征与病理完全缓解相关

Features from Computerized Texture Analysis of Breast Cancers at Pretreatment MR Imaging Are Associated with Response to Neoadjuvant Chemotherapy.
PubMed 文献 · Radiology · 2017-10-04

本回顾性研究纳入85例乳腺癌患者,于新辅助化疗前进行乳腺MR检查,采用二维纹理分析T2加权和增强T1加权图像。T2加权图像峰度与非三阴性乳腺癌的病理完全缓解独立相关(P=0.033),联合T2和增强T1峰度的多变量模型识别三阴性乳腺癌的AUC为0.834。

要点

  • T2加权图像峰度(SSF=2)与非三阴性乳腺癌新辅助化疗后病理完全缓解独立相关(P=0.033)。
  • T2加权图像峰度(SSF=2)在病理完全缓解组与非病理完全缓解组间差异有统计学意义(P=0.015)。
  • 联合T2和增强T1峰度的多变量模型识别三阴性乳腺癌的AUC为0.834。

核心结论

  • 新辅助化疗前MR纹理分析中,峰度似乎与非三阴性乳腺癌的病理完全缓解相关,并可能成为识别三阴性乳腺癌的有前景的生物标志物。

研究设计与样本

  • 回顾性研究,纳入2008年4月10日至2015年3月12日期间接受新辅助化疗前乳腺MR检查的85例患者共85个乳腺癌病灶,获机构审查委员会批准。
  • 采用软件在T2加权MR图像和增强T1加权MR图像上进行二维纹理分析。
  • 比较病理完全缓解组与非病理完全缓解组、三阴性乳腺癌与非三阴性乳腺癌之间的定量参数,并用多元逻辑回归分析确定独立参数。

诊断标准与关键数值

  • 单因素分析中,T2加权图像空间缩放因子(SSF)为2和4的平均像素强度及增强T1加权图像峰度在三阴性乳腺癌与非三阴性乳腺癌间差异有统计学意义(P分别为0.009、0.003和0.001)。
  • T2加权图像峰度(SSF=2)在病理完全缓解组与非病理完全缓解组间差异有统计学意义(P=0.015)。
  • 多元逻辑回归中,T2加权图像峰度与非三阴性乳腺癌的病理完全缓解独立相关(P=0.033)。
  • 联合T2加权和增强T1加权峰度的多变量模型识别三阴性乳腺癌的受试者工作特征曲线下面积为0.834。

临床应用与阅片要点

  • 在新辅助化疗前乳腺MR阅片时,可关注T2加权图像纹理峰度特征,其似乎与非三阴性乳腺癌的病理完全缓解相关。
  • 联合T2加权和增强T1加权峰度的多变量模型可能有助于识别三阴性乳腺癌(AUC=0.834)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate whether features from texture analysis of breast cancers were associated with pathologic complete response (pCR) after neoadjuvant chemotherapy and to explore the association between texture features and tumor subtypes at pretreatment magnetic resonance (MR) imaging. Materials and Methods Institutional review board approval was obtained. This retrospective study included 85 patients with 85 breast cancers who underwent breast MR imaging before neoadjuvant chemotherapy between April 10, 2008, and March 12, 2015. Two-dimensional texture analysis was performed by using software at T2-weighted MR imaging and contrast material-enhanced T1-weighted MR imaging. Quantitative parameters were compared between patients with pCR and those with non-pCR and between patients with triple-negative breast cancer and those with non-triple-negative cancer. Multiple logistic regression analysis was used to determine independent parameters. Results Eighteen tumors (22%) were triple-negative breast cancers. pCR was achieved in 30 of the 85 tumors (35%). At univariate analysis, mean pixel intensity with spatial scaling factor (SSF) of 2 and 4 on T2-weighted images and kurtosis on contrast-enhanced T1-weighted images showed a significant difference between triple-negative breast cancer and non-triple-negative breast cancer (P = .009, .003, and .001, respectively). Kurtosis (SSF, 2) on T2-weighted images showed a significant difference between pCR and non-pCR (P = .015). At multiple logistic regression, kurtosis on T2-weighted images was independently associated with pCR in non-triple-negative breast cancer (P = .033). A multivariate model incorporating T2-weighted and contrast-enhanced T1-weighted kurtosis showed good performance for the identification of triple-negative breast cancer (area under the receiver operating characteristic curve, 0.834). Conclusion At pretreatment MR imaging, kurtosis appears to be associated with pCR to neoadjuvant chemotherapy in non-triple-negative breast cancer and may be a promising biomarker for the identification of triple-negative breast cancer. © RSNA, 2017.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Chamming's F, Ueno Y, Ferré R, et al. Features from Computerized Texture Analysis of Breast Cancers at Pretreatment MR Imaging Are Associated with Response to Neoadjuvant Chemotherapy. Radiology. 2017. PMID: 28980886. doi:10.1148/radiol.2017170143

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。